Method of using catalpic acid to treat hyperinsulinemia
US7834058B2 · kind B2 · utility
1Cited by
2References
9Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | Jul 3, 2008 |
| Grant date | Nov 16, 2010 |
| Priority date | — |
| Expiry date | Jul 12, 2028 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P3/10
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
A method of treating hyperinsulinemia. The method includes administering a therapeutically effective amount of a compound selected from the group consisting of catalpic acid, glyceride esters thereof, pharmaceutically-suitable salts thereof, and combinations thereof. The compound may be administered orally or parenterally.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.